Four-hundredfold overestimation of biopsy mortality
Author:
Affiliation:
1. Memorial Sloan-Kettering Cancer Center; Department of epidemiology and biostatics; New York; NY; USA
2. Department of Urology; Sahlgrenska Academy at the University of Gothenburg; Sweden
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12020_9/fullpdf
Reference12 articles.
1. Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme;Boniol;BJU Int,2012
2. No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer;Carlsson;BJU Int,2011
3. Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan;Kakehi;International Journal of Urology: Official Journal of the Japanese Urological Association,2008
4. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men;Gallina;International Journal of Cancer Journal International du Cancer,2008
5. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;The New England Journal of Medicine,2012
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Four Flawed Arguments Against Prostate-specific Antigen Screening (and 1 Good One);Urology;2015-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3